Safer Sex Program for Young African-American Men
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01439503 |
Recruitment Status
:
Recruiting
First Posted
: September 23, 2011
Last Update Posted
: October 30, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
To evaluate the efficacy of the adapted program a randomized controlled trial enrolling 620 eligible African American men who have sex with men (MSM) will be conducted. Men in the treatment condition will be compared to men receiving the control condition comprised of standard of care counseling from the clinic plus a free bag of condoms and water-based lubricants. This two-arm trial will test four hypotheses:
Aim: To test the efficacy of a brief, clinic-based and theory-guided, intervention designed to reduce STD incidence and risk of HIV acquisition/transmission among young African American men (15-29 years old) having sex with men and presenting for STD testing.
H1. Men randomized to receive the intervention will have a lower incidence rate of laboratory-confirmed STDs at each of three follow-up assessments compared to those receiving the control condition.
H2. Men randomized to receive the intervention will report significantly fewer acts of unprotected penetrative sex (penile-vaginal or penile-anal) between follow-up assessments compared to those receiving the control condition.
H3. Men randomized to receive the intervention will report having significantly fewer unprotected penetrative sex partners (for penile-vaginal or penile-anal sex) between follow-up assessments compared to those receiving the control condition.
H4. Men randomized to receive the intervention will report having significantly fewer negative experiences with condom use between follow-up assessments compared to those receiving the control condition.
H5. Men randomized to receive the intervention will demonstrate significantly greater improvement in condom application skills, throughout the 12-month study, compared to those receiving the control condition.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Gonorrhea Chlamydia Trichomoniasis Syphilis HIV Infections | Behavioral: Intervention | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 620 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Prevention |
Official Title: | A Brief, Clinic-Based, Safer Sex Program for Young African-American Men |
Study Start Date : | September 2012 |
Estimated Primary Completion Date : | May 2018 |
Estimated Study Completion Date : | May 2019 |

Arm | Intervention/treatment |
---|---|
No Intervention: Control
Men receiving the control condition will be comprised of standard of care counseling from the clinic plus a variety of free condoms and water-based lubricants. They will also provide a specimen for STD testing, and receive text message questions for 12 weeks. The text messaging system will be used to collect self-reported dependent variables from men on a weekly basis. Texting will also serve as a constant method of contact between the PD and the enrolled men to remind them of follow-up assessments. In addition, the participants will complete the ACASI questionnaire to assess their sexual behavior, as well as demonstrate their condom application ability.
|
|
Experimental: Treatment
Men receiving the treatment condition will receive text messages each week after their enrollment date and this will continue for 12 weeks to collect self-reported dependent variables. Text messaging will also be used to confirm and remind men about the day of each follow-up assessment. Each participant will also provide a specimen for STD testing, as well complete the ACASI questionnaire to assess sexual behavior and demonstrate their condom application ability. These participants will also be provided with a variety of free condoms and water-based lubricants. In addition, men in the treatment condition will also be enrolled in an education program.
|
Behavioral: Intervention
The intervention will consist of an education program. The education program includes providing the ability to enjoy condom use through improved skills related to finding the right "fit and feel" of condoms, using lubricants that are compatible with latex, negotiating condom use, negotiating sex, and talking with new and existing sex partners about ways to "sexualize" condoms.
|
- The frequency of unprotected sex rather than frequency of condom use will be used as the primary outcome measure. [ Time Frame: 12 months (per participant) ]This will be achieved through the use of a centralized text messaging service. Once each week (throughout the 12-month observation period) men will receive questions, via text. The data from these weekly questions will be cumulated to form "3-month" variables that correspond with the STD-testing intervals between baseline and the first follow-up assessment and between the first follow-up assessment and the second one (at 6 months), as well as the "6-month" variables corresponding to the STD-testing interval between the 6-month assessment and the final assessment at 12 months.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 15 Years to 29 Years (Child, Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 15-29 years of age
- Identifying as an African American Male
- Males must be presenting themselves for STD testing
- Males must report recently (past 3 months) engaging in penile-anal sex with other males as a "top" (meaning the insertive partner)
Exclusion Criteria:
- Males not identifying as African American
- Males older than 29 years of age
- Males that are not patients of the STD clinic
- Males who have not engaged in penile-anal sex with other males as a "top" within the past 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01439503
Contact: Richard A Crosby, PhD | 859-257-5620 | rcros2@email.uky.edu | |
Contact: Leandro A Mena, MD | 601-984-5560 | lmena@umc.edu |
United States, Mississippi | |
Mississippi State Department of Health STD Clinic | Recruiting |
Jackson, Mississippi, United States, 39216 | |
Contact: Leandro A Mena, MD 601-984-5560 lmena@umc.edu |
Principal Investigator: | Richard A Crosby, PhD | University of Kentucky | |
Principal Investigator: | Leandro A Mena, MD | University of Mississippi Health Care |
Responsible Party: | Richard Crosby, PhD/DDI Endowed Professor and Chair, University of Kentucky |
ClinicalTrials.gov Identifier: | NCT01439503 History of Changes |
Other Study ID Numbers: |
11-0204-F3R 1R01MH092226-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | September 23, 2011 Key Record Dates |
Last Update Posted: | October 30, 2017 |
Last Verified: | October 2017 |
Additional relevant MeSH terms:
HIV Infections Gonorrhea Syphilis Trichomonas Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |
Neisseriaceae Infections Gram-Negative Bacterial Infections Bacterial Infections Sexually Transmitted Diseases, Bacterial Infection Genital Diseases, Male Genital Diseases, Female Treponemal Infections Spirochaetales Infections Protozoan Infections Parasitic Diseases |